Established in 2001, Beijing Bohui Innovation Biotechnology Group Co., Ltd. ("Bohui Group") has evolved into a high-tech life sciences enterprise integrating R&D, production, sales, and after-sales services. Through continuous innovation, it has developed multiple technological platforms including microfluidic nucleic acid detection, atomic spectroscopy, quantum dot immunoassays, and mass spectrometry, successfully achieving industrialization and large-scale commercial deployment. The company has undertaken major national scientific-industrialization projects such as the 12th/13th Five-Year Plans and National 863 Program, establishing state-approved high-end R&D platforms and talent development bases.

Bohui Biopharmaceutical (Hebei) Co., Ltd.("Hebei Bohui"), originally established as Shijiazhuang Blood Products Institute and formerly known as Hebei Da'an Pharmaceutical Co., Ltd., was founded in 1992 with a registered capital of RMB 1.145 billion. Located in Luquan District, Shijiazhuang, the company is a leading biopharmaceutical enterprise specializing in plasma collection, product R&D, manufacturing, and sales. As a key supplier, it plays a vital role in ensuring the safe supply of blood products in the Beijing-Tianjin-Hebei region. In recognition of its strategic importance, the company was included in the Hebei Province's strategic emerging biopharmaceutical industry development projects in both 2015 and 2020.

Bohui Biopharmaceutical (Yunnan) Co., Ltd. ("Yunnan Bohui") was registered and established in June 2019. the company is located at No. 800 Ruihe West Road, Qujing Economic and Technological Development Zone, spanning the 53,333-sqm (80.3 mu) with 80,000-sqm construction area. Its infrastructure includes: Annual 1,500-ton plasma processing center,Warehousing complex,Testing/engineering/R&D centers.

Guangdong Weilun Biopharmaceutical Co., Ltd. ("Guangdong Weilun"), founded in 1994 within Zhupu Industrial Zone, Haojiang District, Shantou, Guangdong Province. this state-designated blood products manufacturer holds national GMP certification . It specializes in R&D, production, and distribution of biologicals (blood products) and pharmaceuticals.

Bohui Biopharmaceutical Co., Ltd. ("Langfang Bohui"), established in 1995 and located in Yanjiao High-Tech Development Zone, Langfang City. As a national high-tech enterprise deeply aligned with the key strategic emerging industries specified in China's 14th Five-Year Plan, it holds production qualifications for vaccines and blood products. Specifically in the vaccine sector, it possesses the only product approval license for rabies vaccine in Hebei Province, and its current main product is Rabies Vaccine (Hamster Kidney Cell) for Human Use.

Advion Interchim Scientific (AIS) is a strategic cooperation alliance brand jointly established by Advion (USA) and Interchim (France). As a world-leading provider of life science solutions, it is committed to offering innovative analytical instruments, purification systems, and chemical synthesis technologies for the pharmaceutical, biotechnology, chemical research, and clinical diagnostics fields. Advion (USA) is located in Ithaca, New York State, USA, while Interchim (France) is situated in Montluçon, France. AIS has established regional operation centers and branch offices in major global markets, building a service network covering five continents and operating in over 50 countries and regions worldwide.